martes, 16 de junio de 2020

STAT Plus: As efficacy of Constellation’s blood cancer drug wanes, the debate over its future ratchets higher

https://www.statnews.com/2020/06/12/as-efficacy-of-constellations-blood-cancer-drug-wanes-the-debate-over-its-future-ratchets-higher/?utm_source=STAT+Newsletters&utm_campaign=ae0c7590d6-Cancer_Briefing&utm_medium=email&utm_term=0_8cab1d7961-ae0c7590d6-149692869
Cancer Briefing

STAT Plus: As efficacy of Constellation’s blood cancer drug wanes, the debate over its future ratchets higher

By ADAM FEUERSTEIN

KEVIN MACKENZIE/UNIVERSITY OF ABERDEEN/WELLCOME
Whether the latest data on the experimental drug for myelofibrosis patients is good or bad news depends on your point of view.

No hay comentarios: